Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · IEX Real-Time Price · USD
15.12
+0.37 (2.51%)
May 31, 2024, 4:00 PM EDT - Market closed
Cross Country Healthcare Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for CCRN stock have an average target of 20.83, with a low estimate of 16 and a high estimate of 26. The average target predicts an increase of 37.76% from the current stock price of 15.12.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CCRN stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 6 | 6 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 9 | 9 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $24 → $21 | Buy | Maintains | $24 → $21 | +38.89% | May 6, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $21 → $19 | Strong Buy | Maintains | $21 → $19 | +25.66% | May 2, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $26 → $24 | Buy | Maintains | $26 → $24 | +58.73% | Feb 27, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $22 → $16 | Hold | Maintains | $22 → $16 | +5.82% | Feb 22, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $24 → $21 | Strong Buy | Maintains | $24 → $21 | +38.89% | Feb 22, 2024 |
Financial Forecast
Revenue This Year
1.41B
from 2.02B
Decreased by -30.04%
Revenue Next Year
1.44B
from 1.41B
Increased by 1.63%
EPS This Year
0.72
from 2.05
Decreased by -64.74%
EPS Next Year
0.99
from 0.72
Increased by 37.21%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.5B | 1.6B | 1.6B |
| Avg | 1.4B | 1.4B | 1.5B |
| Low | 1.3B | 1.3B | 1.4B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -25.6% | 11.0% | 13.9% |
| Avg | -30.0% | 1.6% | 6.4% |
| Low | -34.2% | -8.6% | -1.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.92 | 1.33 | 1.58 |
| Avg | 0.72 | 0.99 | 1.16 |
| Low | 0.53 | 0.65 | 0.76 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -54.9% | 84.5% | 58.8% |
| Avg | -64.7% | 37.2% | 17.2% |
| Low | -74.2% | -10.5% | -22.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.